Impact of Availability of Showerpatch for Patients With Intravenous Catheters (ISIC)
Comparison of Showerpatch Versus Other Measures to Protect Intravenous Catheter Entry Site During Bathing Activities
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3000
- University Hospitals Leuven
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- able to read and speak Dutch and to fill out a web-based questionnaire
- patients with an IV catheter (peripheral catheter, midline, peripherally inserted central catheter (PICC), Central Venous catheter (CVC), tunnelled catheter or implantable port) with an expected dwell time IV therapy of at least 14 days and with or without a prospect of discharge to the home setting with the IV catheter in situ in the foreseen study period
- physically able to wash themselves
- with access to the internet
Exclusion Criteria:
- Bedridden patients
- Patients who have already participated in an earlier stage of the ISIC study
- Patients with more than one lumen of the catheter continuously connected to an infusion line
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Shower patch IV catheter protection
Newly developed waterproof catheter dressing may be used for bathing activities
|
Shower patch will be available for the patient for bathing activities
|
|
Other: Conventional IV catheter protection
No specific dressing will be provided to the patient to protect the catheter entry site during bathing activities.
|
No Shower patch will be provided during study period
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported autonomy score regarding bathing activities
Time Frame: Weekly until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
autonomy regarding bathing activities will be scored on a newly developed autonomy scale on a weekly basis
|
Weekly until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number and type of bathing activities
Time Frame: Weekly reported, until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Number and type of bathing activities per week
|
Weekly reported, until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
|
Catheter dressing status: wet
Time Frame: Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Expressed on a 3-point scale from 0 which means not wet to 2 totally wet
|
Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
|
Catheter dressing status: loose
Time Frame: Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Expressed on a 3-point scale from 0 which means not loose to 2 totally loose
|
Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
|
Time needed from a caregiver
Time Frame: Weekly reported, until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Time expressed in minutes per week
|
Weekly reported, until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
|
Material consumption regarding IV entry site care for bathing activities
Time Frame: Weekly reported, until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Description of material which was used for catheter dressing protection and/or for the extra dressing change and/or extra securement of the dressing afterwards.
|
Weekly reported, until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
|
Clinical signs of local infection
Time Frame: Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Redness, tenderness, warmth, swelling or pus leakage recorded on a yes/no basis
|
Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
|
Laboratory-Confirmed Bloodstream Infection
Time Frame: Until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Collected at the end of the study by retrospective analysis of the patient file in case of hospital admission
|
Until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin irritation after application of Showerpatch
Time Frame: Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Redness or other sign of skin irritation at the place where adhesive of the new protection dressing had contact with the skin on a yes/no basis
|
Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
|
Catheter/Huber needle status
Time Frame: Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Expressed on a 3-point scale from 0 which means correct in place to 2 totally removed
|
Before and after bathing activities, reported until catheter removal which is expected on an average after 2 weeks or up to 8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Godelieve A Goossens, PhD, Universitaire Ziekenhuizen KU Leuven
Publications and helpful links
General Publications
- O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011 May;39(4 Suppl 1):S1-34. doi: 10.1016/j.ajic.2011.01.003. No abstract available.
- Oakley C, Wright E, Ream E. The experiences of patients and nurses with a nurse-led peripherally inserted central venous catheter line service. Eur J Oncol Nurs. 2000 Dec;4(4):207-18. doi: 10.1054/ejon.2000.0099.
- Molloy D, Smith LN, Aitchison T. Cytotoxic chemotherapy for incurable colorectal cancer: living with a PICC-line. J Clin Nurs. 2008 Sep;17(18):2398-407. doi: 10.1111/j.1365-2702.2008.02359.x.
- Do AN, Ray BJ, Banerjee SN, Illian AF, Barnett BJ, Pham MH, Hendricks KA, Jarvis WR. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis. 1999 Feb;179(2):442-8. doi: 10.1086/314592.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- S57372
- FC13145773 (Other Grant/Funding Number: Flander's care)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.